BioPharma Dive - Latest News

US risks losing biotech edge to China, report warns

“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrot...

Rallybio discontinues lead drug for rare maternal disorder

The company has decided to switch gears following disappointing data for a monoc...

Rallybio discontinues lead candidate for rare maternal ...

The company has decided to switch gears following disappointing data for a monoc...

Tango Therapeutics cuts nearly one-fifth of staff

“We, like so many others, have been forced to take steps to extend our cash runw...

Judge permanently blocks Trump admin plan to cap NIH fu...

Universities are waiting cautiously as the agency's unilateral plan to cut billi...

RFK Jr. won’t appear before Senate panel this week

HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 1...

GSK targets neurodegenerative diseases with latest lice...

The pharma giant is wagering potentially billions of dollars on technology from ...

Obesity drug data helps Rhythm defy market slide

Study results in a rare form of obesity could help the company expand use of Imc...

Trump rejects Biden-era plan to let Medicare cover obes...

The decision is a setback for GLP-1 drugmakers, though it's not entirely surpris...

Trial monitors recommend Elevidys studies continue; Nov...

Sarepta and Roche will share the monitors' findings with EMA to resolve a tempor...

Oz confirmed by Senate to lead CMS

Mehmet Oz, a physician and TV personality, takes office as HHS lays off thousand...

M&A recap: Big pharma starts the year mostly avoiding b...

Just two acquisitions in the first quarter, that of Intra-Cellular Therapies and...

Trump installs sweeping new tariffs, but pharma dodges ...

The president will impose a baseline 10% tariff on all countries, as well as hig...

Roche halts testing of Sarepta Duchenne gene therapy in...

The Swiss drugmaker, which holds European rights to Elevidys, suspended three tr...

FDA misses approval deadline for Novavax’s COVID-19 vac...

The delayed decision comes amid a major organizational shakeup that included the...

Biotech ‘megarounds’ hold steady as startups, VCs wait ...

More than three-quarters of private biotech investment tracked by BioPharma Dive...

Trump installs sweeping new tariffs, but pharma appears...

The president will impose a baseline 10% tariff on all countries, as well as hig...

Leqembi’s EU review drags on; Sanofi gets a new develop...

The European Commission has referred Eisai and Biogen’s application to an appeal...

New genetic medicine CDMO acquires Landmark Bio

Artis BioSolutions joins a host of startups trying to improve development and ma...

FDA device office hit in HHS layoffs

Teams working on device communications and policy were cut from the agency on Tu...

‘A cruel April Fool’s joke’: HHS layoffs characterized ...

The sweeping workforce reduction that began Tuesday was made worse by mistakes a...

Newly launched genetic medicine CDMO acquires Landmark Bio

Artis BioSolutions joins a host of startups trying to improve development and ma...

Judge overturns FDA’s lab developed test regulation, si...

A Texas judge vacated the FDA’s final rule, which was strongly opposed by the la...

HHS begins layoffs in chaotic fashion

Reduction-in-force notices went out Tuesday morning to employees across HHS. At ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.